Pictet Asset Management’s ‘Megatrending 2025’ highlights structural shifts across society, the environment, and technology that will shape the global economy. To narrow it down further, the asset manager identified seven key trends: tech beyond AI, 3D chips, CDMOs, trees reimagined, solving the gridlock, fight against floods and smart nutrition.
For instance, in healthcare, biotech innovations, including AI-driven drug development and anti-obesity treatments, present new investment opportunities.
“We believe megatrends are a crucial source of long-run revenue and earnings growth. As such, they also have a bearing on long-term investment returns. That’s why we use them as the basis for each of our thematic equity portfolios,” says Stephen Freedman, Head of research and sustainability, Thematic Equities, at Pictet.
Read the full paper here.
Read more

Columbia Threadneedle Investments
What’s next for the US in 2025?
US equities remain attractive despite high valuations, but rising government debt could pose a threat to bond markets.

Quant Investing
AI and quantitative investing
Artificial intelligence applications go way beyond stock selection.

Schroders
Looking ahead: 30-year return forecasts
Higher returns are expected across asset classes, driven by stronger productivity growth for equities and elevated long-term central bank rate projections for bonds.

Bellevue Asset Management
Demographics and AI drive MedTech stocks
MedTech investment case: What makes it attractive, which trends stand out?